These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 27771111)
1. Ziconotide intrathecal delivery as treatment for secondary therapeutic failure of motor cortex stimulation after 6 years. Voirin J; Darie I; Fischer D; Simon A; Rohmer-Heitz I; Proust F Neurochirurgie; 2016 Oct; 62(5):284-288. PubMed ID: 27771111 [TBL] [Abstract][Full Text] [Related]
2. Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study. Mohammed SI; Eldabe S; Simpson KH; Brookes M; Madzinga G; Gulve A; Baranidharan G; Radford H; Crowther T; Buchser E; Perruchoud C; Batterham AM Neuromodulation; 2013; 16(6):576-81; discussion 582. PubMed ID: 23205907 [TBL] [Abstract][Full Text] [Related]
3. Intrathecal ziconotide and baclofen provide pain relief in seven patients with neuropathic pain and spasticity: case reports. Saulino M; Burton AW; Danyo DA; Frost S; Glanzer J; Solanki DR Eur J Phys Rehabil Med; 2009 Mar; 45(1):61-7. PubMed ID: 19156022 [TBL] [Abstract][Full Text] [Related]
5. Acute rhabdomyolysis in a patient with long-term exposure to intrathecal ziconotide: a case report. Horazeck C; Huh AS; Huh BK Pain Pract; 2015 Mar; 15(3):E34-9. PubMed ID: 25565390 [TBL] [Abstract][Full Text] [Related]
6. [Ziconotide: an innovative alternative for intense chronic neuropathic pain]. Valía-Vera JC; Villanueva VL; Asensio-Samper JM; López-Alarcón MD; de Andrés JA Rev Neurol; 2007 Dec 1-15; 45(11):665-9. PubMed ID: 18050098 [TBL] [Abstract][Full Text] [Related]
7. Successful reduction of neuropathic pain associated with spinal cord injury via of a combination of intrathecal hydromorphone and ziconotide: a case report. Saulino M Spinal Cord; 2007 Nov; 45(11):749-52. PubMed ID: 17310258 [TBL] [Abstract][Full Text] [Related]
8. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects. Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373 [TBL] [Abstract][Full Text] [Related]
9. Effect of First-Line Ziconotide Intrathecal Drug Therapy for Neuropathic Pain on Disability, Emotional Well-Being, and Pain Catastrophizing. Shao MM; Khazen O; Hellman A; Czerwinski M; Dentinger R; DiMarzio M; Gillogly M; Hadanny A; Argoff C; Pilitsis JG World Neurosurg; 2021 Jan; 145():e340-e347. PubMed ID: 33096281 [TBL] [Abstract][Full Text] [Related]
10. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study. Deer TR; Kim C; Bowman R; Tolentino D; Stewart C; Tolentino W Pain Physician; 2009; 12(4):E291-6. PubMed ID: 19668287 [TBL] [Abstract][Full Text] [Related]
11. Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain. Wermeling DP; Berger JR Pharmacotherapy; 2006 Mar; 26(3):395-402. PubMed ID: 16503720 [TBL] [Abstract][Full Text] [Related]
12. Intrathecal ziconotide for neuropathic pain: a review. Pain Pract; ; . PubMed ID: 19682321 [TBL] [Abstract][Full Text] [Related]